These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30892508)

  • 1. [Long-acting reversible contraception methods in the Brazilian Unified National Health System: the debate on women's (in)discipline].
    Brandão ER
    Cien Saude Colet; 2019 Mar; 24(3):875-879. PubMed ID: 30892508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant.
    Apter D; Briggs P; Tuppurainen M; Grunert J; Lukkari-Lax E; Rybowski S; Gemzell-Danielsson K
    Fertil Steril; 2016 Jul; 106(1):151-157.e5. PubMed ID: 27016644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability of the levonorgestrel releasing-intrauterine system and etonogestrel implant: one-year results of an observational study.
    Short M; Dallay D; Omokanye S; Hanisch JU; Inki P
    Eur J Contracept Reprod Health Care; 2012 Feb; 17(1):79-88. PubMed ID: 22200172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
    Modesto W; Bahamondes MV; Bahamondes L
    Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
    Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
    Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experiences with the levonorgestrel-releasing intrauterine system in Kenya: qualitative interviews with users and their partners.
    Nanda G; Rademacher K; Solomon M; Mercer S; Wawire J; Ngahu R
    Eur J Contracept Reprod Health Care; 2018 Aug; 23(4):303-308. PubMed ID: 30198796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two year continuation rates of contraceptive methods in France: a cohort study from the French national health insurance database.
    Agostini A; Godard C; Laurendeau C; Benmahmoud Zoubir A; Lafuma A; Lévy-Bachelot L; Gourmelen J; Linet T
    Eur J Contracept Reprod Health Care; 2018 Dec; 23(6):421-426. PubMed ID: 30499732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attendance of an Initial Follow-up Visit after Long-Acting Reversible Contraception Insertion and Method Continuation Among Adolescents and Young Adults: A Retrospective Study.
    Bryson AE; Cabral HJ; Coles MS
    J Pediatr Adolesc Gynecol; 2021 Aug; 34(4):525-529. PubMed ID: 33486086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline.
    Mavranezouli I;
    Hum Reprod; 2008 Jun; 23(6):1338-45. PubMed ID: 18372257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge and attitudes about long-acting reversible contraception among Latina women who desire sterilization.
    White K; Hopkins K; Potter JE; Grossman D
    Womens Health Issues; 2013; 23(4):e257-63. PubMed ID: 23816156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK.
    Varney SJ; Guest JF
    Pharmacoeconomics; 2004; 22(17):1141-51. PubMed ID: 15612832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting reversible contraception: a review in special populations.
    Prescott GM; Matthews CM
    Pharmacotherapy; 2014 Jan; 34(1):46-59. PubMed ID: 24130075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications and continuation rates associated with 2 types of long-acting contraception.
    Berenson AB; Tan A; Hirth JM
    Am J Obstet Gynecol; 2015 Jun; 212(6):761.e1-8. PubMed ID: 25555662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of progestin-only long-acting contraception on metabolic markers in obese women.
    Bender NM; Segall-Gutierrez P; Najera SO; Stanczyk FZ; Montoro M; Mishell DR
    Contraception; 2013 Sep; 88(3):418-25. PubMed ID: 23410714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal Trends in the Uptake and Continuation of the Etonogestrel Implant in a Large Private Practice Setting.
    Howard DL; Ford A; Ceballos S; Volker KW
    J Womens Health (Larchmt); 2018 Feb; 27(2):191-195. PubMed ID: 28976797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contraception with the new intrauterine systems: a winning choice if shared!
    di Spiezio Sardo A; Mastantuoni E; De Angelis MC; Zizolfi B
    Minerva Ginecol; 2019 Oct; 71(5):377-384. PubMed ID: 31698892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate postabortion initiation of levonorgestrel implants reduces the incidence of births and abortions at 2 years and beyond.
    Rose SB; Garrett SM; Stanley J
    Contraception; 2015 Jul; 92(1):17-25. PubMed ID: 25818594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
    Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
    Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial.
    Carvalho N; Margatho D; Cursino K; Benetti-Pinto CL; Bahamondes L
    Fertil Steril; 2018 Nov; 110(6):1129-1136. PubMed ID: 30396557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of long-acting, progestin-only contraception in Europe: a two-year prospective, non-interventional study.
    Short M; Dallay D; Omokanye S; Stauch K; Inki P
    Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):29-38. PubMed ID: 24289528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.